Vanda Pharmaceuticals Shares Are Trading Higher After the US Supreme Court Reportedly Declined to Hear the Company's Case Regarding the Invalidation of Patents for Hetlioz.
Vanda Pharmaceuticals Shares Are Trading Higher After the US Supreme Court Reportedly Declined to Hear the Company's Case Regarding the Invalidation of Patents for Hetlioz.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.